The historical rank and industry rank for Fine Foods & Pharmaceuticals NTM SpA's Return-on-Tangible-Equity or its related term are showing as below:
MIL:FF'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -7.77 Med: -0.19 Max: 9.94
Current: 5.68
During the past 10 years, Fine Foods & Pharmaceuticals NTM SpA's highest Return-on-Tangible-Equity was 9.94%. The lowest was -7.77%. And the median was -0.19%.
MIL:FF's Return-on-Tangible-Equity is ranked worse than 58% of 1874
companies
in the Consumer Packaged Goods industry
Industry Median: 7.695
vs MIL:FF: 5.68
Fine Foods & Pharmaceuticals NTM SpA (MIL:FF) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Fine Foods & Pharmaceuticals NTM SpA Return-on-Tangible-Equity Related Terms
Fine Foods & Pharmaceuticals NTM SpA Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fine Foods & Pharmaceuticals NTM SpA Return-on-Tangible-Equity Chart
MIL:FF vs KHC, GIS, HRL: Return-on-Tangible-Equity Comparison
For the Packaged Foods subindustry, Fine Foods & Pharmaceuticals NTM SpA's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fine Foods & Pharmaceuticals NTM SpA Return-on-Tangible-Equity vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Fine Foods & Pharmaceuticals NTM SpA's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Fine Foods & Pharmaceuticals NTM SpA's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 2.82% mean?
Fine Foods & Pharmaceuticals NTM SpA (MIL:FF) has a Return-on-Tangible-Equity of 2.82% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Fine Foods & Pharmaceuticals NTM SpA and its competitors. According to the industry distribution chart, Fine Foods & Pharmaceuticals NTM SpA ranks #1087 out of 1874 companies in the Consumer Packaged Goods industry, placing it in the top 58%.
Is Fine Foods & Pharmaceuticals NTM SpA's Return-on-Tangible-Equity too high?
Fine Foods & Pharmaceuticals NTM SpA's current Return-on-Tangible-Equity is 2.82%. The Consumer Packaged Goods industry median Return-on-Tangible-Equity is 7.70. Fine Foods & Pharmaceuticals NTM SpA's value of 2.82% is 63.4% below this industry median. Based on the distribution chart, Fine Foods & Pharmaceuticals NTM SpA ranks #1087 out of 1874 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Fine Foods & Pharmaceuticals NTM SpA has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fine Foods & Pharmaceuticals NTM SpA's Return-on-Tangible-Equity compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Fine Foods & Pharmaceuticals NTM SpA ranks #1087 out of 1874 companies for Return-on-Tangible-Equity. This places Fine Foods & Pharmaceuticals NTM SpA in the lower half of its industry. The industry median Return-on-Tangible-Equity is 7.70. Fine Foods & Pharmaceuticals NTM SpA's value of 2.82% is 63.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Consumer Packaged Goods company?
The median Return-on-Tangible-Equity among Consumer Packaged Goods companies is 7.70, based on 1,874 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fine Foods & Pharmaceuticals NTM SpA's current Return-on-Tangible-Equity of 2.82% is 63.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Fine Foods & Pharmaceuticals NTM SpA and its competitors. For the Consumer Packaged Goods industry, the median Return-on-Tangible-Equity is 7.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fine Foods & Pharmaceuticals NTM SpA's current Return-on-Tangible-Equity is 2.82%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fine Foods & Pharmaceuticals NTM SpA stock overvalued right now?
Based on GuruFocus' analysis, Fine Foods & Pharmaceuticals NTM SpA (MIL:FF) is currently considered Fairly Valued. The stock's GF Value™ is €9.17, compared to a current price of €9.08 — trading 1% below its estimated fair value. The current Return-on-Tangible-Equity is 2.82% and 63.4% below the Consumer Packaged Goods industry median of 7.70. Fine Foods & Pharmaceuticals NTM SpA's overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Fine Foods & Pharmaceuticals NTM SpA (MIL:FF), the current Return-on-Tangible-Equity is 2.82% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fine Foods & Pharmaceuticals NTM SpA (MIL:FF) Overvalued in 2026?
Based on GuruFocus' analysis, Fine Foods & Pharmaceuticals NTM SpA stock appears to be undervalued.
The current stock price of €9.08 is trading 1% below its estimated GF Value™ of €9.17.
GuruFocus considers Fine Foods & Pharmaceuticals NTM SpA to be Fairly Valued.
Key valuation signals for MIL:FF:
Return-on-Tangible-Equity: 2.82%
GF Value™: €9.17 vs. price of €9.08 (1% below fair value)
Industry Position: 63.4% below the Consumer Packaged Goods median (#1087 of 1874)
No single metric tells the full story. See the MIL:FF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fine Foods & Pharmaceuticals NTM SpA Business Description
Fine Foods & Pharmaceuticals NTM SpA is engaged in contract development and manufacturing of pharmaceuticals, nutraceuticals, and medical devices in solid oral forms. The company produces pharmaceutical products such as powders and granules, tablets, film tablets, and hard gelatin capsules, packed in sachets, blisters, and pillows.
77GF Score
Get the complete analysis for MIL:FF
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:FF has been successfully added to your 
